KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $144.0 million.

  • Quest Diagnostics' Capital Expenditures rose 3584.91% to $144.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $492.0 million, marking a year-over-year increase of 3155.08%. This contributed to the annual value of $425.0 million for FY2024, which is 416.67% up from last year.
  • Per Quest Diagnostics' latest filing, its Capital Expenditures stood at $144.0 million for Q3 2025, which was up 3584.91% from $108.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Capital Expenditures ranged from a high of $147.0 million in Q4 2022 and a low of $63.0 million during Q1 2022
  • Over the past 5 years, Quest Diagnostics' median Capital Expenditures value was $105.0 million (recorded in 2023), while the average stood at $105.7 million.
  • Data for Quest Diagnostics' Capital Expenditures shows a peak YoY increase of 10158.73% (in 2023) and a maximum YoY decrease of 5102.04% (in 2023) over the last 5 years.
  • Quarter analysis of 5 years shows Quest Diagnostics' Capital Expenditures stood at $144.0 million in 2021, then increased by 2.08% to $147.0 million in 2022, then crashed by 51.02% to $72.0 million in 2023, then skyrocketed by 70.83% to $123.0 million in 2024, then increased by 17.07% to $144.0 million in 2025.
  • Its Capital Expenditures stands at $144.0 million for Q3 2025, versus $108.0 million for Q2 2025 and $117.0 million for Q1 2025.